STOCK TITAN

[FWP] Morgan Stanley Free Writing Prospectus

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Form 144 filed for Hagerty, Inc. (HGTY) discloses that Robert I. Kauffman/Aldel LLC intends to sell up to 4,600 common shares around 30 June 2025 through Merrill Lynch on the NYSE. Based on the filing’s stated market value of $46,276, the proposed sale represents less than 0.01 % of the company’s 90.0 million shares outstanding.

The seller originally acquired 3.5 million shares on 2 Dec 2021 as part of the PIPE financing linked to Hagerty’s SPAC business-combination. Over the preceding three months (17 Mar – 27 Jun 2025) the filer reported 53 separate open-market transactions totaling approximately 507,000 shares and $4.9 million in gross proceeds. The new notice therefore continues an established pattern of incremental insider disposals.

No operational, earnings, or strategic information about Hagerty is provided; the document is strictly a compliance notice under Rule 144. While the share volume is modest relative to the float, continuing insider sales may weigh on investor sentiment.

Il modulo 144 presentato per Hagerty, Inc. (HGTY) rivela che Robert I. Kauffman/Aldel LLC intende vendere fino a 4.600 azioni ordinarie intorno al 30 giugno 2025 tramite Merrill Lynch sul NYSE. In base al valore di mercato indicato nel modulo di 46.276 $, la vendita proposta rappresenta meno dello 0,01% delle 90 milioni di azioni in circolazione della società.

Il venditore ha originariamente acquisito 3,5 milioni di azioni il 2 dicembre 2021 come parte del finanziamento PIPE legato alla business combination SPAC di Hagerty. Nei tre mesi precedenti (dal 17 marzo al 27 giugno 2025), il dichiarante ha segnalato 53 transazioni sul mercato aperto per un totale di circa 507.000 azioni e 4,9 milioni di dollari di proventi lordi. La nuova comunicazione quindi prosegue un modello consolidato di cessioni incrementali da parte di insider.

Non vengono fornite informazioni operative, sugli utili o strategiche riguardanti Hagerty; il documento è esclusivamente una comunicazione di conformità ai sensi della Regola 144. Sebbene il volume delle azioni sia modesto rispetto al flottante, le continue vendite da parte degli insider potrebbero influenzare negativamente il sentiment degli investitori.

El formulario 144 presentado para Hagerty, Inc. (HGTY) revela que Robert I. Kauffman/Aldel LLC planea vender hasta 4.600 acciones ordinarias alrededor del 30 de junio de 2025 a través de Merrill Lynch en la NYSE. Según el valor de mercado declarado en la presentación de 46.276 $, la venta propuesta representa menos del 0,01% de las 90 millones de acciones en circulación de la compañía.

El vendedor adquirió originalmente 3,5 millones de acciones el 2 de diciembre de 2021 como parte del financiamiento PIPE vinculado a la combinación de negocios SPAC de Hagerty. En los tres meses previos (del 17 de marzo al 27 de junio de 2025), el declarante reportó 53 transacciones abiertas en el mercado por un total aproximado de 507.000 acciones y 4,9 millones de dólares en ingresos brutos. La nueva notificación continúa así un patrón establecido de disposiciones incrementales por parte de insiders.

No se proporciona información operativa, de ganancias o estratégica sobre Hagerty; el documento es estrictamente un aviso de cumplimiento bajo la Regla 144. Aunque el volumen de acciones es modesto en relación con el flotante, las ventas continuas por parte de insiders podrían afectar negativamente el sentimiento de los inversores.

Hagerty, Inc. (HGTY)에 대해 제출된 Form 144는 Robert I. Kauffman/Aldel LLC2025년 6월 30일경 Merrill Lynch를 통해 NYSE에서 최대 4,600 보통주를 매도할 계획임을 공개합니다. 제출서에 명시된 시장 가치 46,276달러를 기준으로, 제안된 매도는 회사의 9,000만 주 발행 주식의 0.01% 미만에 해당합니다.

매도자는 원래 2021년 12월 2일 Hagerty의 SPAC 사업 합병과 연계된 PIPE 자금 조달의 일환으로 350만 주를 취득했습니다. 최근 3개월간(2025년 3월 17일~6월 27일) 제출자는 약 53건의 개별 공개시장 거래를 보고했으며, 총 약 507,000주490만 달러의 총 수익을 기록했습니다. 이번 신규 공지는 점진적인 내부자 매도 패턴을 지속하는 것입니다.

Hagerty에 관한 운영, 수익 또는 전략 정보는 제공되지 않았으며; 이 문서는 엄격히 규칙 144에 따른 준수 통지입니다. 주식 거래량은 유통 주식 대비 적은 편이지만, 지속적인 내부자 매도는 투자자 심리에 부정적인 영향을 미칠 수 있습니다.

Le formulaire 144 déposé pour Hagerty, Inc. (HGTY) révèle que Robert I. Kauffman/Aldel LLC prévoit de vendre jusqu'à 4 600 actions ordinaires autour du 30 juin 2025 via Merrill Lynch à la NYSE. Sur la base de la valeur marchande indiquée dans le dépôt de 46 276 $, la vente proposée représente moins de 0,01 % des 90 millions d'actions en circulation de la société.

Le vendeur a initialement acquis 3,5 millions d'actions le 2 décembre 2021 dans le cadre du financement PIPE lié à la fusion d'entreprise SPAC de Hagerty. Au cours des trois mois précédents (du 17 mars au 27 juin 2025), le déclarant a rapporté 53 transactions distinctes sur le marché ouvert totalisant environ 507 000 actions et 4,9 millions de dollars de produits bruts. Cette nouvelle notification poursuit donc un schéma établi de cessions progressives par des initiés.

Aucune information opérationnelle, de résultats ou stratégique concernant Hagerty n'est fournie ; le document est strictement un avis de conformité en vertu de la règle 144. Bien que le volume d'actions soit modeste par rapport au flottant, les ventes continues des initiés pourraient peser sur le sentiment des investisseurs.

Das eingereichte Formular 144 für Hagerty, Inc. (HGTY) offenbart, dass Robert I. Kauffman/Aldel LLC beabsichtigt, bis zu 4.600 Stammaktien um den 30. Juni 2025 über Merrill Lynch an der NYSE zu verkaufen. Basierend auf dem im Formular angegebenen Marktwert von 46.276 $ stellt der geplante Verkauf weniger als 0,01 % der 90 Millionen ausstehenden Aktien des Unternehmens dar.

Der Verkäufer erwarb ursprünglich 3,5 Millionen Aktien am 2. Dezember 2021 im Rahmen der PIPE-Finanzierung, die mit der SPAC-Business-Combination von Hagerty verbunden ist. In den vorangegangenen drei Monaten (17. März – 27. Juni 2025) meldete der Einreicher 53 einzelne Transaktionen am offenen Markt mit insgesamt etwa 507.000 Aktien und 4,9 Millionen Dollar Bruttoerlös. Die neue Meldung setzt somit ein etabliertes Muster schrittweiser Insider-Verkäufe fort.

Es werden keine operativen, Gewinn- oder strategischen Informationen zu Hagerty bereitgestellt; das Dokument ist streng genommen eine Compliance-Mitteilung gemäß Regel 144. Obwohl das Aktienvolumen im Verhältnis zum Streubesitz gering ist, könnten fortlaufende Insider-Verkäufe die Anlegerstimmung belasten.

Positive
  • Regulatory transparency: The insider continues to file timely Form 144 notices, giving investors visibility into planned and historical sales.
  • Low relative volume: Proposed 4,600-share sale represents less than 0.01 % of outstanding common stock, limiting market-impact risk.
Negative
  • Persistent insider selling: Approximately 507,000 shares sold over the prior three months for $4.9 million suggests continued divestment by a significant shareholder.
  • Potential sentiment drag: Repeated Form 144 filings may foster negative perception regarding insider confidence, even if fundamental impact is small.

Insights

TL;DR: Modest but ongoing insider selling; sentiment negative, fundamental impact minimal.

The filing signals another small tranche (4,600 shares) from Robert I. Kauffman’s sizeable PIPE position. Cumulatively, he has sold roughly 507 k shares (≈0.6 % of shares outstanding) for $4.9 m in the last quarter. The new notice is immaterial to liquidity or valuation metrics but reinforces a three-month insider selling trend that can dampen short-term price momentum and raise questions about insider confidence. No business fundamentals are affected, so long-term intrinsic value remains unchanged.

TL;DR: Routine Rule 144 disclosure; transparency positive, governance risk low.

The filer is complying with disclosure rules, providing granular sale history and acquisition background. Volumes are within Rule 144 limits and under 1 % of outstanding shares, mitigating market-manipulation concerns. The continued liquidation of a SPAC-era PIPE position is common post-lock-up and does not, by itself, indicate governance deficiencies. Impact on broader shareholder rights or control dynamics appears negligible.

Il modulo 144 presentato per Hagerty, Inc. (HGTY) rivela che Robert I. Kauffman/Aldel LLC intende vendere fino a 4.600 azioni ordinarie intorno al 30 giugno 2025 tramite Merrill Lynch sul NYSE. In base al valore di mercato indicato nel modulo di 46.276 $, la vendita proposta rappresenta meno dello 0,01% delle 90 milioni di azioni in circolazione della società.

Il venditore ha originariamente acquisito 3,5 milioni di azioni il 2 dicembre 2021 come parte del finanziamento PIPE legato alla business combination SPAC di Hagerty. Nei tre mesi precedenti (dal 17 marzo al 27 giugno 2025), il dichiarante ha segnalato 53 transazioni sul mercato aperto per un totale di circa 507.000 azioni e 4,9 milioni di dollari di proventi lordi. La nuova comunicazione quindi prosegue un modello consolidato di cessioni incrementali da parte di insider.

Non vengono fornite informazioni operative, sugli utili o strategiche riguardanti Hagerty; il documento è esclusivamente una comunicazione di conformità ai sensi della Regola 144. Sebbene il volume delle azioni sia modesto rispetto al flottante, le continue vendite da parte degli insider potrebbero influenzare negativamente il sentiment degli investitori.

El formulario 144 presentado para Hagerty, Inc. (HGTY) revela que Robert I. Kauffman/Aldel LLC planea vender hasta 4.600 acciones ordinarias alrededor del 30 de junio de 2025 a través de Merrill Lynch en la NYSE. Según el valor de mercado declarado en la presentación de 46.276 $, la venta propuesta representa menos del 0,01% de las 90 millones de acciones en circulación de la compañía.

El vendedor adquirió originalmente 3,5 millones de acciones el 2 de diciembre de 2021 como parte del financiamiento PIPE vinculado a la combinación de negocios SPAC de Hagerty. En los tres meses previos (del 17 de marzo al 27 de junio de 2025), el declarante reportó 53 transacciones abiertas en el mercado por un total aproximado de 507.000 acciones y 4,9 millones de dólares en ingresos brutos. La nueva notificación continúa así un patrón establecido de disposiciones incrementales por parte de insiders.

No se proporciona información operativa, de ganancias o estratégica sobre Hagerty; el documento es estrictamente un aviso de cumplimiento bajo la Regla 144. Aunque el volumen de acciones es modesto en relación con el flotante, las ventas continuas por parte de insiders podrían afectar negativamente el sentimiento de los inversores.

Hagerty, Inc. (HGTY)에 대해 제출된 Form 144는 Robert I. Kauffman/Aldel LLC2025년 6월 30일경 Merrill Lynch를 통해 NYSE에서 최대 4,600 보통주를 매도할 계획임을 공개합니다. 제출서에 명시된 시장 가치 46,276달러를 기준으로, 제안된 매도는 회사의 9,000만 주 발행 주식의 0.01% 미만에 해당합니다.

매도자는 원래 2021년 12월 2일 Hagerty의 SPAC 사업 합병과 연계된 PIPE 자금 조달의 일환으로 350만 주를 취득했습니다. 최근 3개월간(2025년 3월 17일~6월 27일) 제출자는 약 53건의 개별 공개시장 거래를 보고했으며, 총 약 507,000주490만 달러의 총 수익을 기록했습니다. 이번 신규 공지는 점진적인 내부자 매도 패턴을 지속하는 것입니다.

Hagerty에 관한 운영, 수익 또는 전략 정보는 제공되지 않았으며; 이 문서는 엄격히 규칙 144에 따른 준수 통지입니다. 주식 거래량은 유통 주식 대비 적은 편이지만, 지속적인 내부자 매도는 투자자 심리에 부정적인 영향을 미칠 수 있습니다.

Le formulaire 144 déposé pour Hagerty, Inc. (HGTY) révèle que Robert I. Kauffman/Aldel LLC prévoit de vendre jusqu'à 4 600 actions ordinaires autour du 30 juin 2025 via Merrill Lynch à la NYSE. Sur la base de la valeur marchande indiquée dans le dépôt de 46 276 $, la vente proposée représente moins de 0,01 % des 90 millions d'actions en circulation de la société.

Le vendeur a initialement acquis 3,5 millions d'actions le 2 décembre 2021 dans le cadre du financement PIPE lié à la fusion d'entreprise SPAC de Hagerty. Au cours des trois mois précédents (du 17 mars au 27 juin 2025), le déclarant a rapporté 53 transactions distinctes sur le marché ouvert totalisant environ 507 000 actions et 4,9 millions de dollars de produits bruts. Cette nouvelle notification poursuit donc un schéma établi de cessions progressives par des initiés.

Aucune information opérationnelle, de résultats ou stratégique concernant Hagerty n'est fournie ; le document est strictement un avis de conformité en vertu de la règle 144. Bien que le volume d'actions soit modeste par rapport au flottant, les ventes continues des initiés pourraient peser sur le sentiment des investisseurs.

Das eingereichte Formular 144 für Hagerty, Inc. (HGTY) offenbart, dass Robert I. Kauffman/Aldel LLC beabsichtigt, bis zu 4.600 Stammaktien um den 30. Juni 2025 über Merrill Lynch an der NYSE zu verkaufen. Basierend auf dem im Formular angegebenen Marktwert von 46.276 $ stellt der geplante Verkauf weniger als 0,01 % der 90 Millionen ausstehenden Aktien des Unternehmens dar.

Der Verkäufer erwarb ursprünglich 3,5 Millionen Aktien am 2. Dezember 2021 im Rahmen der PIPE-Finanzierung, die mit der SPAC-Business-Combination von Hagerty verbunden ist. In den vorangegangenen drei Monaten (17. März – 27. Juni 2025) meldete der Einreicher 53 einzelne Transaktionen am offenen Markt mit insgesamt etwa 507.000 Aktien und 4,9 Millionen Dollar Bruttoerlös. Die neue Meldung setzt somit ein etabliertes Muster schrittweiser Insider-Verkäufe fort.

Es werden keine operativen, Gewinn- oder strategischen Informationen zu Hagerty bereitgestellt; das Dokument ist streng genommen eine Compliance-Mitteilung gemäß Regel 144. Obwohl das Aktienvolumen im Verhältnis zum Streubesitz gering ist, könnten fortlaufende Insider-Verkäufe die Anlegerstimmung belasten.

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,097

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

Worst-of SPX, NDX and RTY Contingent Income Securities due August 3, 2028

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.

Terms

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Underliers:

S&P 500® Index (SPX), Nasdaq-100 Index® (NDX) and Russell 2000® Index (RTY)

Contingent coupon:

7.75% to 9.75% per annum

Coupon payment dates:

Quarterly

Coupon barrier level:

70% of the initial level for each underlier

Downside threshold level:

70% of the initial level for each underlier

Pricing date:

July 31, 2025

Final observation date:

July 31, 2028

Maturity date:

August 3, 2028

CUSIP:

61778NCQ2

Estimated value:

$962.10 per security, or within $45.00 of that estimate

Preliminary pricing supplement:

https://www.sec.gov/Archives/edgar/data/895421/000183988225035576/ms9097_424b2-19404.htm

1All payments are subject to our credit risk

 

Hypothetical Payment at Maturity1

% Change in Closing Level of the Worst Performing Underlier

Payment at Maturity per Security (excluding any contingent coupon payable at maturity)

+100.00%

$1,000.00

+80.00%

$1,000.00

+60.00%

$1,000.00

+40.00%

$1,000.00

+20.00%

$1,000.00

0.00%

$1,000.00

-20.00%

$1,000.00

-30.00%

$1,000.00

-31.00%

$690.00

-40.00%

$600.00

-60.00%

$400.00

-80.00%

$200.00

-100.00%

$0.00


 

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlier(s)

For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Securities

The securities do not guarantee the return of any principal.

The securities do not provide for the regular payment of interest.

Payment of the contingent coupon is based on the closing levels of the underliers on only the related observation date at the end of the related interest period.

Investors will not participate in any appreciation in the value of any underlier.

The market price of the securities may be influenced by many unpredictable factors.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The securities will not be listed on any securities exchange and secondary trading may be limited.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oYou are exposed to the price risk of each underlier.

oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a significant loss on your investment than if the securities were linked to just one underlier.

oAdjustments to an underlying index could adversely affect the value of the securities.

The securities are subject to risks associated with small-capitalization companies.

Risks Relating to Conflicts of Interest

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

 

FAQ

How many HGTY shares does Robert I. Kauffman plan to sell under this Form 144?

The notice covers up to 4,600 common shares to be sold on or about 30 June 2025.

What percentage of Hagerty’s outstanding shares do the proposed sales represent?

The 4,600 shares equal less than 0.01 % of the 90,032,391 shares outstanding.

How many HGTY shares has the filer sold in the past three months?

Form 144 lists about 507,000 shares sold between 17 March and 27 June 2025.

When and how were the shares originally acquired?

Aldel LLC acquired 3.5 million shares on 2 Dec 2021 through PIPE financing tied to Hagerty’s SPAC merger.

Does the filing include any financial or operational updates on Hagerty?

No. The document is limited to insider sale disclosures under Rule 144 and contains no business performance information.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

220.95B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK